ARCHIVES

Imbruvica Improves PFS, OS In Phase III CLL Study

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

Panel Recommends 5-FU/Levamisole For Adjuvant Stage 3 Colon Cancer

April 27, 1990

CIS Recompetition Approved, But BSC Delays Decision On Matching Requirement

May 15, 1987

DCT to Fund 11 Surgical Oncology Grants. Consider Switching $700,000 To Program Project Renewals

November 2, 1979

ACS’ Freeman; Declare New War In Cancer; Poor Get Substandard Treatment, Lost Dignity

July 21, 1989

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

December 31, 2010

FDA carries Action On Two Cancer Drugs Over To 1996

January 5, 1996